Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 9 | 22008805 | missense variant | G/A | snv | 4.5E-06 |
|
Neoplasms | 0.700 | 0 | ||||||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 9 | 22010005 | intron variant | T/A;G | snv |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.040 | 9 | 22010005 | intron variant | T/A;G | snv |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2011 | 2013 | ||||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 9 | 22009699 | intron variant | G/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.040 | 9 | 22005994 | missense variant | C/T | snv | 8.6E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 9 | 22007331 | intron variant | C/A | snv | 1.2E-02 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 9 | 22003791 | 3 prime UTR variant | T/C | snv | 7.3E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.683 | 0.480 | 9 | 22003224 | 3 prime UTR variant | C/T | snv | 0.32 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 9 | 22010413 | intron variant | A/G | snv | 6.8E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 9 | 22005994 | missense variant | C/T | snv | 8.6E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.695 | 0.520 | 9 | 22003368 | 3 prime UTR variant | G/A;T | snv |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |